Snavely, Anna C. http://orcid.org/0000-0001-6916-4255
Foley, Kristie
Dharod, Ajay
Dignan, Mark
Brower, Holly
Wright, Elena
Miller, David P. Jr.
Funding for this research was provided by:
National Cancer Institute (R01CA218416)
Article History
Received: 13 March 2023
Accepted: 23 March 2023
First Online: 14 April 2023
Declarations
:
: The Wake Forest University Health Sciences IRB approved this study (IRB00048919). This trial is being conducted under a waiver of informed patient consent as the research involves no more than minimal risk and could not be practicably carried out without the waiver. For staff and provider participants, this trial is being conducted under a waiver of signed consent as no sensitive information is collected.
: Not applicable - no identifying images or other personal or clinical details of participants are presented here or will be presented in reports of the trial results. The study information sheet described in {26a} is available from the corresponding author on request.
: DM and AD are the coinventors of mPATH™. DM, AD, and Wake Forest University Health Sciences have an ownership interest in the mPATH™ program. The other authors declare that they have no competing interests.